Group 1 - The stock of Jin Yu Biological Technology Co., Ltd. decreased by 1.3% on December 30, trading at 15.19 yuan per share, with a total market capitalization of 16.887 billion yuan [1] - The company, established on March 13, 1993, and listed on January 15, 1999, primarily engages in the research, production, and sales of veterinary biological products, with main business revenue composition being 94.42% from biopharmaceuticals, 3.18% from other income, and 2.40% from supplementary sources [1] Group 2 - The fund under招商基金 holds a significant position in Jin Yu Biological, with the 招商中证畜牧养殖ETF (516670) increasing its holdings by 834,000 shares in the third quarter, totaling 3.6029 million shares, which represents 3.95% of the fund's net value, ranking as the eighth largest holding [2] - The 招商中证畜牧养殖ETF (516670) was established on March 18, 2021, with a current size of 878 million yuan, yielding a return of 13.79% this year, ranking 3260 out of 4195 in its category, and a one-year return of 11.04%, ranking 3318 out of 4179 [2] Group 3 - The fund manager of 招商中证畜牧养殖ETF (516670) is Liu Chongjie, who has been in the position for 7 years and 242 days, managing total assets of 32.873 billion yuan, with the best fund return during his tenure being 102.53% and the worst being -35.89% [3]

Investment Rating - Industry Rating: Recommended [4] Core Insights - The pork industry continues to face losses, with a focus on pig farming opportunities. The average price of live pigs is 11.59 CNY/kg, down 0.46% week-on-week. The total breeding sow inventory is 39.9 million heads, down 1.1% month-on-month and 2.1% year-on-year. The industry is experiencing ongoing losses, with self-bred and purchased pig farming losses at 130.11 CNY/head and 162.80 CNY/head respectively. The recent anti-dumping ruling may alleviate domestic pork supply pressure, leading to accelerated capacity reduction [2][12]. Summary by Sections Planting Industry Chain - The Ministry of Agriculture and Rural Affairs has initiated winter crop seed supervision checks to ensure seed safety for the upcoming spring and summer planting. The checks focus on key crops such as corn, rice, soybeans, cotton, and vegetables. The commercialization of genetically modified technology is expected to accelerate, enhancing self-sufficiency rates of key varieties. Recommended stocks include Beidahuang and Suqian Agricultural Development [1][11]. Pig Farming - The average price of live pigs is reported at 11.59 CNY/kg, with a slight decrease of 0.46% from the previous week. The average price for pig futures is 11,469 CNY/ton, reflecting a 1.07% increase. The average weight of pigs post-slaughter is 89.57 kg, with a month-on-month increase of 3.21% in slaughter volume [12][62][65]. Recommended Stocks - For pig farming, recommended stocks include: 1. Livestock sector: Lihua Stock, Muyuan Food, Shuanghui Development, Dekang Agriculture, Jingji Zhino, and Wens Foodstuff 2. Feed sector: Haida Group 3. Animal health sector: Jinhai Biological, Biological Shares, Placo, and Zhongmu Shares [2][12].

Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery industry [1][42] Core Views - The SW agriculture, forestry, animal husbandry, and fishery industry slightly underperformed the CSI 300 index, with an increase of 1.55% from December 12 to December 25, 2025, lagging behind the index by approximately 0.43 percentage points [11][14] - All sub-sectors recorded positive returns during the same period, with notable increases in agricultural product processing (3.04%), animal health (2.95%), planting (2.28%), fishery (1.56%), breeding (0.81%), and feed (0.29%) [14][15] - The overall price-to-book (PB) ratio for the industry is approximately 2.79 times, indicating a slight recovery in valuation, which remains at a historical low level, around the 62.7 percentile since 2006 [18][24] Industry Important Data - **Pig Farming**: The average price of external three-way cross pigs increased from 11.45 CNY/kg to 11.59 CNY/kg during the reporting period. The cost of corn and soybean meal has slightly decreased, with corn priced at 2338.04 CNY/ton and soybean meal at 3102 CNY/ton as of December 25, 2025 [22][24] - **Profitability**: As of December 26, 2025, the profit for self-bred pigs was -130.11 CNY/head, and for purchased piglets, it was -162.8 CNY/head, showing a reduction in losses compared to the previous two weeks [27] - **Poultry Farming**: The average price of broiler chicks was 3.59 CNY/chick, showing a slight increase, while the average price for white feather broilers was 7.82 CNY/kg, with profitability improving to 0.89 CNY/chick [29][33] Industry Insights - The report emphasizes the potential for a rebound in pig prices as the seasonal consumption peak approaches, with a focus on the high inventory of breeding sows and the opportunities for leading pig farming companies [42][43] - In poultry farming, the report highlights the recovery in white feather broiler prices and the improvement in profitability, suggesting a positive outlook for leading poultry companies [42][43] - The report also notes growth potential in the domestic pet market and the expected increase in export volumes, recommending attention to promising domestic leaders in this sector [42][43]

证券之星消息，12月26日动物保健板块较上一交易日下跌1.01%，生物股份领跌。当日上证指数报收于 3963.68，上涨0.1%。深证成指报收于13603.89，上涨0.54%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600195 | 中牧股份 | 8.00 | 0.13% | 9.70万 | 7760.85万 | | 920729 | 永顺生物 | 8.83 | 0.11% | 4509.29 | 398.88万 | | 002141 | 后丰控股 | 3.71 | -0.27% | 15.43万 | 5712.69万 | | 300119 | 瑞普生物 | 19.37 | -0.31% | 2.94万 | 5701.35万 | | 688526 | 科前生物 | 15.62 | -0.38% | 1.90万 | 2965.26万 | | 688098 | 申联生物 | 8.91 | -0.67% | 2.81万 | 2511.39万 | | 603566 ...

证券代码：603739 证券简称：蔚蓝生物公告编号：2025-056 青岛蔚蓝生物股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 担保对象及基本情况 ■ ● 累计担保情况 ■ 一、担保情况概述 （二）内部决策程序 上述担保事项已经公司2025年4月25日召开的第五届董事会第十六次会议审议通过，并经公司于2025年5 月16日召开的2024年年度股东会批准。具体内容详见公司分别于2025年4月26日、2025年5月17日在上海 证券交易所网站披露的《青岛蔚蓝生物股份有限公司关于2025年度对外担保额度预计的公告》（公告编 号：2025-011）、《青岛蔚蓝生物股份有限公司2024年年度股东会决议公告》（公告编号：2025- 022）。 二、被担保人基本情况 ■ 三、担保协议的主要内容 1、债权人：中国光大银行股份有限公司青岛城阳支行 6、保证期间：自具体授信业务合同或协议约定的受信人履行债务期限届满之日起三年。 7、保证范围：受信人在主合同项下应向授信人偿还或 ...

Group 1 - The core announcement is regarding the major shareholder, Inner Mongolia Jinyu Biological Holdings Co., Ltd., planning to increase its stake in Jinyu Biotechnology Co., Ltd. with a total investment of no less than RMB 50 million and no more than RMB 100 million within 12 months from the announcement date [1][2] - The increase in shares is supported by a special loan commitment from China Minsheng Bank, which will provide a loan of up to RMB 90 million for the share purchase, with a loan term of 36 months [2] - The remaining funds for the share increase will come from the major shareholder's own resources, indicating a strong commitment to the company's long-term value [2] Group 2 - The announcement emphasizes the confidence of the major shareholder in the company's future stable development and long-term investment value [1] - The company assures that the announcement does not contain any false records, misleading statements, or major omissions, and takes legal responsibility for the accuracy and completeness of the content [1] - The company will fulfill its information disclosure obligations if any risks arise during the implementation of the share increase plan [2]

Summary of Key Points Core Viewpoint - On December 24, several A-share listed companies disclosed their shareholding changes, with notable increases in holdings from companies like Guizhou Moutai and others, while 18 companies reported reductions in their shareholdings [1][3]. Group 1: Shareholding Increases - **Biological Shares**: Major shareholder obtained a commitment letter for a special loan to increase holdings [2]. - **Marter Shares**: The controlling shareholder and chairman Liu Aisen plans to increase holdings by no less than 100 million yuan [2]. - **Guizhou Moutai**: Plans to repurchase shares through centralized bidding [2]. - **Donghong Shares**: Plans to repurchase shares worth between 30 million to 60 million yuan [2]. Group 2: Shareholding Reductions - **Kaifa Electric**: Shareholders Zhao Le, Wen Guowang, and Zhang Xiaoyi plan to reduce holdings by no more than 0.70% [2]. - **Zhuhai Guanyu**: Shareholders Ningbo Huijin and Zhuhai Lengquan plan to reduce holdings by no more than 3% [2]. - **Lite New Materials**: Controlling shareholder Wang Kunming plans to reduce holdings by no more than 3% [2]. - **Sanhui Electric**: Shareholder Wu Baofu plans to reduce holdings by no more than 2% [2]. - **Xuedilong**: Plans to reduce no more than 4.8856 million shares of repurchased stock [2]. - **Jindun Shares**: Shareholder Gaoxin Investment plans to reduce holdings by no more than 1%, and Founder Securities plans to reduce by no more than 3% [2]. - **Tianhai Defense**: China Great Wall Asset reduced holdings by 3.0278 million shares from December 22 to December 23 [2]. - **Zhangyuan Tungsten**: Controlling shareholder's reduction plan has been completed [2]. - **Chaojie Shares**: Controlling shareholder reduced 974,400 shares from December 8 to December 24 [2]. - **Hengdian East Magnetic**: Controlling shareholder plans to reduce holdings by no more than 1% [2]. - **Luxin Investment**: Controlling shareholder Luxin Group plans to reduce holdings by no more than 1% [2]. - **Sunglow Power**: Four shareholders collectively reduced 423,700 shares [2]. - **He富中国**: Controlling shareholder He富 Hong Kong reduced 9,000 shares on December 24 [2]. - **Tuojing Technology**: The largest shareholder, the National Fund, reduced 1.83 million shares from December 17 to December 24 [2]. - **Little Bear Electric**: Shareholder Long Shaohong plans to reduce holdings by no more than 0.64% [2]. - **Chao Xun Communication**: Shanghai Jiuyi Investment Management reduced holdings to 4.99% [2]. - **Caesar Travel**: The third largest shareholder, Jingu Trust, plans to reduce holdings by no more than 3% [2].

Core Viewpoint - The stock of BioShares (600201) experienced a significant decline of 7.69% in a single trading day, with a turnover rate of 10.29% and a total transaction value of 1.799 billion yuan, indicating heightened market activity and investor concern [2]. Group 1: Stock Performance - The stock's price drop was attributed to a deviation of -8.23% from its daily limit, leading to its listing on the exchange's watchlist [2]. - The net selling by the Shanghai-Hong Kong Stock Connect amounted to 71.6877 million yuan, marking it as the largest selling entity for the day [2]. - The stock saw a net inflow of 46.8376 million yuan from major funds, with large orders contributing 35.8611 million yuan and big orders adding 10.9764 million yuan [2]. Group 2: Trading Data - The top five trading departments accounted for a total transaction value of 359 million yuan, with buying totaling 148 million yuan and selling reaching 211 million yuan, resulting in a net selling of 63.219 million yuan [2]. - The largest buying department was Guotai Junan Securities Headquarters, with a purchase amount of 41.4571 million yuan [3]. - The largest selling department was the Shanghai-Hong Kong Stock Connect, with a selling amount of 71.6877 million yuan [3]. Group 3: Financial Performance - For the first three quarters, the company reported a revenue of 1.042 billion yuan, reflecting a year-on-year growth of 7.38% [3]. - The net profit for the same period was 161 million yuan, showing a year-on-year decline of 4.85% [3]. Group 4: Margin Trading Data - As of December 23, the margin trading balance for the stock was 1.643 billion yuan, with a financing balance of 1.637 billion yuan and a securities lending balance of 6.0756 million yuan [2]. - Over the past five days, the financing balance increased by 70.1125 million yuan, representing a growth of 4.48% [2]. - The securities lending balance decreased by 432.9 thousand yuan, indicating a decline of 6.65% [2].

本次增持计划可能存在因资本市场情况发生变化或目前尚无法预判的其他 风险因素导致增持计划无法完成实施的风险。如增持计划实施过程中出现相关风 险情形，公司将及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 金宇生物技术股份有限公司董事会 证券代码：600201 证券简称：生物股份 公告编号：临 2025-063 2025 年 12 月 25 日 关于大股东取得增持专项贷款承诺函的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 金宇生物技术股份有限公司（以下简称"公司"）于 2025 年 12 月 24 日在上 海证券交易所网站（www.sse.com.cn）披露了《金宇生物技术股份有限公司关于 大股东增持股份计划的公告》（公告编号：临 2025-062），公司大股东内蒙古金 宇生物控股有限公司（以下简称"生物控股"）基于对公司未来持续稳定发展的 信心和长期投资价值的认可，同时为增强投资者信心，拟自公告披露之日起 12 个月内，通过上海证券交易所系统以集中竞价方式增持公司股份，增持总金额不 低于人民币 ...

格隆汇12月24日丨生物股份(600201.SH)公布，中国民生银行股份有限公司呼和浩特分行（简称"民生银 行"）已为生物控股出具《贷款承诺函》，同意为生物控股增持本公司A股股份提供专项贷款支持，贷 款金额最高不超过人民币9000万元，贷款期限36个月。除上述贷款外，本次A股股份增持的其余资金为 生物控股自有资金。 ...